期刊
HEART RHYTHM
卷 12, 期 7, 页码 1524-1531出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.hrthm.2015.03.011
关键词
Atrial fibrillation; Catheter ablation; Left atrial appendage closure; Stroke prevention
资金
- St. Jude Medical
- Medtronic
- Biotronik
- Boston Scientific
- Biosense
- Hansen Medical
- Webster
- Daiichi Sankyo
- Topera
- Pfizer
- Bristol Myers Squibb
- Bayer
- Sanofi Aventis
BACKGROUND Left atrial appendage (LAA) closure devices have been introduced recently as an alternative for oral anticoagulation (OAC) in patients with nonvalvular atrial fibrillation (AF). Because of potential overlap of ablation target areas and the previously implanted LAA closure device, as well as potential complications such as mechanical damage to the device, left atrial (LA) ablation remains a subject of debate in these patients. OBJECTIVE We report on the feasibility and clinical efficacy of LA ablation after implantation of LAA closure devices. METHODS Eight patients (6 men; age 69 8 years) with symptomatic paroxysmal AF (n = 5) or persistent AF (mean CHA(2)DS(2)-VASc score 3.6 +/- 0.7, mean HAS-BLED score 3.6 +/- 1.5) and previously implanted WATCHMAN (7 patients) or AMPLATZER Cardiac Plug (1 patient) LAA closure devices received radiofrequency-based LA ablation (4 via circumferential pulmonary vein isolation [CPVI], 4 via CPVI and additional LA linear lesions or complex fractionated atrial electrograms) after a mean of 201 days (range 41-756 days) after LAA closure. RESULTS Successful LA ablation was achieved without device interference or periprocedural complications. After a mean of 503 days (range 113-1006 days), transesophageal echocardiography (TEE) was performed in all patients to assess for device-related complications. No device dislocation or leakage was observed. In 1 patient (12.5%), a device-related thrombus was found despite therapeutic OAC with dabigatran. Five patients (63%) remained in stable sinus rhythm, and no bleeding events or stroke occurred during a follow-up of 554 days (range 2181006 days). CONCLUSION LA ablation after LAA closure appears to be feasible. Device-related thrombus formation in 1 patient suggests the need for further TEE examinations after LA ablation after LAA closure device implantation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据